Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 5;6(6):CD009245.
doi: 10.1002/14651858.CD009245.pub3.

Interventions for the treatment of Paget's disease of the vulva

Katharine A Edey  1 , Ernest Allan, John B Murdoch, Susan Cooper, Andrew Bryant
Affiliations

Interventions for the treatment of Paget's disease of the vulva

Katharine A Edey et al. Cochrane Database Syst Rev. .

Abstract

Background: This is an updated version of the original Cochrane Review published in Issue 10, 2013.Extramammary Paget's disease is a rare form of superficial skin cancer. The most common site of involvement is the vulva. It is seen mainly in postmenopausal white women. Paget's disease of the vulva often spreads in an occult fashion, with margins extending beyond the apparent edges of the lesion. There is a range of interventions from surgical to non-invasive techniques or treatments. The challenges of interventions are to remove or treat disease that may not be visible, without overtreatment and with minimisation of morbidity from radical surgery. There is little consensus regarding treatment. Surgery, by default, is the most common treatment, but it is challenging to excise the disease adequately, and recurrence is common, leading to repeated operations, and destruction of anatomy. Alternative treatments of photodynamic therapy, laser therapy, radiotherapy, topical treatments or even chemotherapy have been mooted, and it is important to evaluate the available evidence. It is essential to assess whether newer cell-specific treatments, such as photodynamic therapy and imiquimod, can reduce the need for radical surgery.

Objectives: To evaluate the benefits and harms of different treatment modalities for the management of Paget's disease of the vulva.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via Ovid) and Embase (via Ovid) up to 8 May 2018. We also searched registers of clinical trials, abstracts of scientific meetings and reference lists of review articles.

Selection criteria: We searched for randomised controlled trials (RCTs) and well-designed non-randomised studies that compared different interventions in women with Paget's disease of the vulva, DATA COLLECTION AND ANALYSIS: Two review authors independently assessed whether potentially relevant studies met the inclusion criteria. We found no trials and, therefore, analysed no data.

Main results: The search for the original version of the review identified 635 unique references. We found 31 references (which reported on 30 studies) in full text after inspection of titles and abstracts, but we excluded them all as they did not meet the inclusion criteria. However, we have included a comprehensive narrative account of studies where we identified an analysis of more than 10 women, as this forms the only evidence base in this rare disease. Surgery continues to be the mainstay of treatment in the current literature, with other treatments limited to case reports or treatment of inoperable or recurrent disease.This update between September 2013 and May 2018 identified 35 new studies. None of these met the inclusion criteria. There was only one prospective study of 5% imiquimod in recurrent Paget's disease of the vulva, which although of good quality only included eight women.

Authors' conclusions: Since the last version of the review was published there are many more cases in the literature reporting a clinical response to 5% imiquimod cream. There is one prospective study of eight women treated with 5% imiquimod for recurrent Paget's disease of the vulva, and one prospective trial of 20 women was due to be reported. This increasing evidence for the safety and efficacy of 5% imiquimod will be helpful for women and clinicians alike. Ideally, a multicentre RCT of reasonable size is needed, but ongoing publications of high-quality non-randomised prospective studies will enhance the current available literature.

PubMed Disclaimer

Conflict of interest statement

KE: none known. EA: none known. JM: none known. SC: none known. AB: none known.

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

References

References to studies excluded from this review

Bakalianou 2008 {published data only}
    1. Bakalianou K, Salakos N, Iavazzo C, Paltoglou G, Papadias K, Gregoriou O, et al. Paget's disease of the vulva. A ten‐year experience. European Journal of Gynecologic Oncology 2008;29(4):368‐70. - PubMed
Black 2007 {published data only}
    1. Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynaecologic Oncology 2007;104:547‐50. - PubMed
Cowan 2016 {published data only}
    1. Cowan RA, Black DR, Hoang LN, Park KJ, Soslow RA, Backes FJ, et al. A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynaecologic Oncology 2016;142(1):139‐43. - PMC - PubMed
Crawford 1999 {published data only}
    1. Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, et al. Prognostic factors in Paget's disease of the vulva: a study of 21 cases. International Journal of Gynaecological Pathology 1999;18(4):351‐9. - PubMed
Curtin 1990 {published data only}
    1. Curtin JP, Rubin SC, Jones WB, Hoskins WJ, Lewis JL. Paget's disease of the vulva. Gynecologic Oncology 1990;39:374‐77. - PubMed
Fan 2016 {published data only}
    1. Fan L, Zhu J, Tao X, Xu C. Intraepithelial extramammary Paget's disease of the vulva; the clinicopathological characteristics, Management, and outcome in a study of 18 female patients. Dermatologic Surgery 2016;42(10):1142‐6. - PubMed
Fanning 1999 {published data only}
    1. Fanning JD, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease and recurrence after surgical excision. American Journal of Obstetrics and Gynecology 1999;180:24‐7. - PubMed
Feuer 1990 {published data only}
    1. Feuer GA, Shevchuk M, Calanog A. Vulvar Paget's disease: the need to exclude an invasive lesion. Gynecologic Oncology 1990;38:81‐9. - PubMed
Fishman 1995 {published data only}
    1. Fishman DA, Chambers SK, Schwartz PE, Kohorn EI, Chambers JT. Extramammary Paget's disease of the vulva. Gynaecologic Oncology 1995;56:266‐70. - PubMed
Goldblum 1997 {published data only}
    1. Goldblum JR, Hart WR. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. American Journal of Surgical Pathology 1997;21(10):1178‐87. - PubMed
Kim 2017 {published data only}
    1. Kim SJ, Thompson AK, Zubair AS, Otley CC, Arpey CJ, Baum CL, et al. Surgical treatment and outcomes of patients with extramammary Paget's disease: a cohort study. Dermatologic Surgery 2017;43(5):708‐14. - PubMed
Koss 1968 {published data only}
    1. Koss LG, Ladinsky S, Brockunier A. Paget's disease of the vulva. Obstetrics and Gynaecology 1968;31(4):513‐25. - PubMed
Lee 1977 {published data only}
    1. Lee SC, Roth LM, Ehrlich C, Hall JA. Extramammary Paget's disease of the vulva. Cancer 1977;39:2540‐9. - PubMed
Lee 2010 {published data only}
    1. Lee CW, Song MJ, Lee SH, Kim JH, Lee SJ, Lee KH, et al. Clinicopathologic analysis of extramammary Paget's disease. European Journal of Gynecological Oncology 2010;32(1):34‐6. - PubMed
Long 2017 {published data only}
    1. Long B, Schmitt AR, Weaver AL, McGree M, Bakkum‐Gamez JN, Brewer J, et al. A matter of margins: surgical and pathologic risk factors for recurrence in extramammary Paget's disease. Gynecologic Oncology 2017;2:358‐63. - PubMed
Louis‐Sylvestre 2001 {published data only}
    1. Louis‐Sylvestre C, Haddad B, Paniel BJ. Paget's disease of the vulva‐results of different conservative treatments. European Journal of Obstetrics, Gynaecology and Reproductive Biology 2001;99:253‐5. - PubMed
Machida 2015 {published data only}
    1. Machida H, Moeini A, Roman LD, Matsuo K. Effects of imiquimod on vulva Paget's disease: a systematic review of literature. Gynecologic Oncology 2015;139(1):165‐71. - PMC - PubMed
Martorell‐Calatayud 2009 {published data only}
    1. Martorell‐Calatayud A, Sanmartín‐Jiménez O, Escutia‐Muñoz B, Guillén‐Barona C. Imiquimod topical at 5% as therapeutic alternative in primary extramammary Paget's disease [Imiquimod tópico al 5% como alternativa terapéutica en la enfermedad de Paget extramamaria primaria]. Piel 2009;10:568‐9.
Molinie 1993 {published data only}
    1. Molinie V, Paniel BJ, Lessana‐Leibowitch M, Moyal‐Barracco M, Pelisse M, Escande JP. Paget disease of the vulva: 36 cases [Maladie de Paget vulvaire: 36 cas]. Annales de Dermatologie et de Vénéréologie 1993;120:522‐7. - PubMed
Niikura 2006 {published data only}
    1. Niikura H, Yoshida H, Ito K, Takano T, Watanabe H, Aiba S, et al. Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution. International Journal of Gynecological Cancer 2006;16:1212‐5. - PubMed
Parashurama 2017 {published data only}
    1. Parashurama R, Nama V, Hutson R. Paget's disease of the vulva: a review of 20 years' experience. International Journal of Gynecological Cancer 2017;4:791‐3. - PubMed
Parker 2000 {published data only}
    1. Parker LP, Parker JR, Bodurka‐Bevers D, Deavers M, Bevers MW, Shen‐Gunther J, et al. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynaecologic Oncology 2000;77:183‐9. - PubMed
Parmley 1975 {published data only}
    1. Parmley TH, Woodruff JD, Julian CG. Invasive vulvar Paget's disease. Obstetrics and Gynaecology 1975;46(3):341‐6. - PubMed
Petkovic 2006 {published data only}
    1. Petkovic S, Jeremic K, Vidakovic S, Jeremic J, Lazovic G. Paget's disease of the vulva – a review of our experience. European Journal of Gynaecological Oncology 2006;27(6):611‐2. - PubMed
Pierie 2003 {published data only}
    1. Pierie JE, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. Journal of American College of Surgeons 2003;196:45‐50. - PubMed
Roh 2010 {published data only}
    1. Roh H‐J, Kim D‐Y, Kim J‐H, Kim Y‐M, Kim Y‐K, Nam J‐H. Paget's disease of the vulva: evaluation of recurrence relative to symptom duration, volumetric excision of lesion, and surgical margin status. Acta Obstetricia et Gynaecologica 2010;89:962‐5. - PubMed
Sawada 2018 {published data only}
    1. Sawada M, Kato J, Yamashita T, Yoneta A, Hida T, Horimoto K, et al. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease. Journal of Dermatology 2018;45(2):216‐9. - PubMed
Shaco‐Levy 2010 {published data only}
    1. Shaco‐Levy R, Bean SM, Vollmer RT, Jewell E, Jones EL, Valdes CL, et al. Paget disease of the vulva: a study of 56 cases. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010;149:86‐91. - PubMed
    1. Shaco‐Levy R, Bean SM, Vollmer RT, Papalas JA, Bentley RC, Selim MA, et al. Paget disease of the vulva: a histologic study of 56 cases corelating pathologic features and disease course. International Journal of Gynecological Pathology 2010;29(1):69‐78. - PubMed
Shingleton 1970 {published data only}
    1. Shingleton HM, Fowler WC, Palumbo L, Koch GG. Carcinoma of the vulva, influence of radical operation on cure. Obstetrics and Gynaecology 1970;35(1):1‐6. - PubMed
Stacy 1986 {published data only}
    1. Stacy D, Burrell MO, Franklin EW. Extramammary Paget's disease of the vulva and anus: use of intraoperative frozen‐section margins. American Journal of Obstetrics and Gynecology 1986;155:519‐23. - PubMed
Strempel 1958 {published data only}
    1. Strempel R. Study on Paget's disease of the vulva [Beitrag zum morbus paget der vulva]. Dermatologische Wochenschrif 1958;138(46):1241‐52. - PubMed
Tanaka 2009 {published data only}
    1. Tanaka VD, Sanches JA, Torezan L, Niwa AB, Neto CF. Mammary and extramammary Paget's disease: a study of 14 cases and therapeutic difficulties. Clinics (Sao Paolo) 2009;64(6):599‐606. - PMC - PubMed
Tebes 2002 {published data only}
    1. Tebes S, Cardosi R, Hoffman M. Paget's disease of the vulva. American Journal of Obstetrics and Gynecology 2002;1887:281‐4. - PubMed
Wang 2003 {published data only}
    1. Wang LC, Blanchard A, Judge DE, Lorincz AA, Medenica MM, Busbey S. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. Journal of the American Academy of Dermatology 2003;49(4):769‐72. - PubMed
Zawislak 2004 {published data only}
    1. Zawislak AA, McCarron PA, McCluggae WG, Price JH, Donnelly RF, McClelland HR, et al. Successful photodynamic therapy of vulval Paget's disease using a novel patch‐based delivery system containing 5‐aminolevulinic acid. British Journal of Obstetrics and Gynaecology 2004;111:1143‐5. - PubMed

References to studies awaiting assessment

Fontanelli 2013 {published data only}
    1. Fontanelli R, Papadia A, Martinelli F, Lorusso D, Grijuela B, Merola M, et al. Photodynamic therapy with M‐ALA as non surgical treatment option in patients with primary extramammary Paget's disease. Journal of Clinical Oncology 2013;130:90‐4. - PubMed
Lu 1999 {published data only}
    1. Lu H, Zhu G. Clinicopathologic and immunohistochemical features of vulvar Paget diseases. Chinese Journal of Obstetrics and Gynaecology 1999;34(3):156‐8. - PubMed
Shrestha 2010 {published data only}
    1. Shrestha E. Clinical analysis of 13 cases of vulvar Paget's disease. Journal of Chinese Clinical Medicine 2010;5(6):322‐5.

References to ongoing studies

van der Linden 2017 {published data only}
    1. Linden M, Meeuwis K, Hees C, Dorst E, Bulten J, Bosse T, et al. The Paget trial: a multicenter, observational cohort intervention study for clinical efficacy, safety, and immunological response of topical 5% imiquimod cream for vulvar Paget disease. JMIR Research Protocols 2017; Vol. 6, issue 9:e178. - PMC - PubMed

Additional references

Bertozzi 2009
    1. Bertozzi S, Londero AP, Fruscalzo A, Marchesoni D, Lellé RJ. Paget disease of the vulva: resolution after local treatment with imiquimod – report of a case and review of the literature. Gynakol Geburtshilfliche Rundsch 2009;49(4):326‐30. - PubMed
Bucher 1997
    1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta‐analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683‐91. - PubMed
CTCAE 2006
    1. CTCAE v3.0. Common Terminology Criteria for Adverse Events. ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3... (29 September 2013).
Deeks 2001
    1. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. Systematic Reviews in Health Care: Meta‐analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
GRADEPro GDT 2014 [Computer program]
    1. GRADE Working Group, McMaster University, Hamilton (ON). GRADEpro Guideline Development Tool (GDT)[www.gradepro.org]. Version [insert date of use]. GRADE Working Group, McMaster University, Hamilton (ON), 2014.
Hatch 2008
    1. Hatch KD, Davis JR. Complete resolution of Paget disease of the vulva with imiquimod cream. Journal of Lower Genital Tract Disease 2008;12(2):90‐4. - PubMed
Heymann 1993
    1. Heymann WR. Extramammary Paget's disease. Clinical Dermatology 1993;11:83‐7. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011a
    1. Higgins JP, Altman DG, Sterne JA. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Kanitakis 2007
    1. Kanitakis J. Mammary and extramammary Paget's disease. Journal of the European Academy of Dermatology and Venereology 2007;21(5):581‐90. - PubMed
Langendam 2013
    1. Langendam MW, Akl EA, Dahm P, Glasziou P, Guyatt G, Schunemann HJ. Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews 2013;23(2):81. - PMC - PubMed
Li 2010
    1. Li Q, Gao T, Jiao B, Qi X, Long H, Qiao H, et al. Long‐term follow‐up of in‐situ extramammary Paget's disease in Asian skin types IIII/V treated with photodynamic therapy. Acta Dermato‐Venereologica 2010;90:159‐64. - PubMed
Luk NM 2003
    1. Luk NM, Yu KH, Yeung WK, Choi CL, Teo ML. Extramammary Paget's disease: outcome of radiotherapy with curative intent. Clinical and Experimental Dermatology 2003;28(4):360‐3. - PubMed
Maclean 1995
    1. Maclean AB, Reid WM. Benign and premalignant disease of the vulva. British Journal of Obstetrics and Gynaecology 1995;102:359‐63. - PubMed
Meader 2014
    1. Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3:82. - PMC - PubMed
Moreno‐Arias 2003
    1. Moreno‐Arias GA, Conill C, Sola‐Casas MA, Mascaro‐Galy JM, Grimalt R. Radiotherapy for in situ extramammary Paget disease of the vulva. Journal of Dermatological Treatment 2003;14(2):119‐23. - PubMed
Nardelli 2011
    1. Nardelli AA, Stafinski T, Menon D. Effectiveness of photodynamic therapy for mammary and extra‐mammary Paget's disease: a state of the science review. BMC Dermatology 2011;11:13. - PMC - PubMed
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34. - PubMed
Preti 2003
    1. Preti M, Micheletti L, Massobrio M, Ansai S, Wilkinson EJ. Vulvar Paget disease: one century after first reported. Journal of Lower Genital Tract Disease 2003;7(2):122‐35. - PubMed
Raspagliesi 2006
    1. Raspagliesi F, Fontanelli R, Rossi G, Ditto A, Solima E, Hanozet F, et al. Photodynamic therapy using a methyl ester of 5‐aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. Gynecologic Oncology 2006;103(2):581‐6. - PubMed
Review Manager 2012 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Sendagorta 2010
    1. Sendagorta E, Herranz P, Feito M, Ramírez P, Floristán U, Feltes R, et al. Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod – proposal of a therapeutic schedule. Journal of the European Academy of Dermatology and Venereology 2010;24(4):490‐2. - PubMed
Shieh 2002
    1. Shieh S, Dee AS, Cheyney RT, Frawley NP, Zeitouni NC, Oseroff AR. Photodynamic therapy for the treatment of extramammary Paget's disease. British Journal of Dermatology 2002;146:1000‐5. - PubMed
Tonguc 2011
    1. Tonguc E, Gungor T, Var T, Ozat M, Sahin I, Sirvan L. Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature. Archives of Gynecology and Obstetrics 2011;283(1):97‐101. - PubMed
Tsutsumida 2003
    1. Tsutsumida A, Yamamoto Y, Minakawa H, Yosida T, Kokubu I, Sugihara T. Indications for lymph node dissection in the treatment of extramammary Paget's disease. Dermatological Surgery 2003;29:21‐4. - PubMed
Valentine 1992
    1. Valentine BH, Arena B, Green E. Laser ablation of recurrent Paget's disease of vulva and perineum. Journal of Gynecologic Surgery 1992;8(1):21‐4. - PubMed
Wilkinson 2002
    1. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Human Pathology 2002;33:549‐54. - PubMed
Woodmansee 2006
    1. Woodmansee C, Pillow J, Skinner RB Jr. The role of topical immune response modifiers in skin cancer. Drugs 2006;66(13):1657‐64. - PubMed

References to other published versions of this review

Edey 2013
    1. Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget's disease of the vulva. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD009245.pub2] - DOI - PubMed

Publication types